Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
| Industry | Pharmaceutical Preparations |
| Sector | Health care |
| Employees | 50,000 |
| Headquarters | INDIANAPOLIS, IN |
| Incorporated in | IN |
| Listed on | NYSE |
| Listed since | Jul 9, 1970 |
| Fiscal year ends | December 31 |
| SEC filer category | Large accelerated filer |
| Website | lilly.com |
| SEC company number (CIK) | 59478 |
Company description from Polygon.io. Industry, address and filing details from SEC EDGAR.